D-limonene is the naturally predominant citrus enantiomer of limonene and the specific form most often reported in sweet orange, lemon, lime, and related peel oils. Compared with generic limonene, its literature trail is easier to anchor because many preclinical and safety papers specify the d/R enantiomer directly. Source-grounded evidence supports strong identity data, repeated anti-inflammatory and oxidative-stress-related findings in cell and animal models, and a clear safety pattern in which fresh d-limonene is far less concerning than its oxidized hydroperoxides. For AromaForge, this makes d-limonene a high-relevance citrus constituent with moderate preclinical depth and important storage and oxidation caveats.
Chemical identity and composition
PubChem lists D-limonene as C10H16 with InChIKey XMGQYMWWDOXHJM-JTQLQIEISA-N and IUPAC name (4R)-1-methyl-4-prop-1-en-2-ylcyclohexene. The local archive already uses this enantiomer-specific constituent in highly citrus-driven records such as Brazilian sweet orange, while spearmint separately reports the l/S enantiomer.
Aroma and practical use
- Use the recorded sweet, orange-like, citrus-peel, fresh, terpenic descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
macrophage cytokine suppression
A direct constituent study reported that D-limonene inhibited nitric oxide, prostaglandin E2, and pro-inflammatory cytokine production in activated macrophages.
Measured: nitric oxide, prostaglandin E2, and cytokine production
This experimental finding does not establish benefit, dose or safety in people using this blend.
rat colitis protection
A rat colitis paper concluded that d-limonene demonstrated significant anti-inflammatory effects and modulated intestinal barrier and inflammatory responses.
Measured: intestinal inflammation and barrier response
This experimental finding does not establish benefit, dose or safety in people using this blend.
murine dermal inflammation and repair
A murine study reported that d-limonene reduced inflammatory lesion severity and lowered serum IL-6 and TNF-alpha while supporting skin-repair outcomes.
Measured: lesion severity, IL-6, TNF-alpha, and tissue repair
This experimental finding does not establish benefit, dose or safety in people using this blend.
contact allergy to hydroperoxides
Human patch-test literature reports that hydroperoxides of d-limonene are frequent contact allergens, while the non-oxidized terpene is much less informative for screening.
Measured: allergy prevalence to oxidized d-limonene derivatives
Apply this finding only to the studied preparation, participants, route and outcome. It does not establish the same result for a custom oil blend.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
No numeric constituent-specific use limit is available here. Missing is not an unrestricted-use clearance.
The best-supported safety concern is oxidation: hydroperoxides and other oxidation products of d-limonene are established contact allergens in dermatology literature.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
A 2013 safety review reported that d-limonene oxidation products or metabolites can act as skin irritants in animals and humans.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
This record does not support medical or oral-use recommendations; the evidence used here is identity, toxicology review, and preclinical pharmacology.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
downregulation of inflammatory mediators
In macrophage work, D-limonene reduced LPS-induced nitric oxide, prostaglandin E2, and cytokine production, supporting an inflammation-modulating pathway interpretation.
This experimental finding does not establish benefit, dose or safety in people using this blend.
reduced dermal inflammation markers
A murine dermal inflammation study reported reduced lesion severity and lower IL-6 and TNF-alpha with d-limonene treatment, giving a second preclinical mechanism signal in skin-related inflammation.
This experimental finding does not establish benefit, dose or safety in people using this blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- Most direct d-limonene benefit literature remains preclinical and should not be translated into therapeutic claims.
- Human clinical efficacy evidence for isolated d-limonene was not verified in this pass.
- This record does not attempt to reconcile every commercial citrus source that labels material as d-limonene versus simply limonene.
- No constituent-specific numeric dermal reference is available here.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.